VMP 33631311000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Deferasirox 180mg tablets
BNF code 0901030K0AAAEAE
Virtual Therapeutic Moiety Deferasirox
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Deferasirox
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 180.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Deferasirox 180mg tablets (Accord-UK Ltd)
Deferasirox 180mg tablets (Amarox Ltd)
Deferasirox 180mg tablets (Consilient Health Ltd)
Deferasirox 180mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Deferasirox 180mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Deferasirox 180mg tablets (MSN Laboratories Europe Ltd)
Deferasirox 180mg tablets (Sandoz Ltd)
Deferasirox 180mg tablets (Teva UK Ltd)
Deferasirox 180mg tablets (Torrent Pharma (UK) Ltd)
Deferasirox 180mg tablets (Viatris UK Healthcare Ltd)
Deferasirox 180mg tablets (Zentiva Pharma UK Ltd)
Exjade 180mg tablets (Novartis Pharmaceuticals UK Ltd)
Virtual Medicinal Product Packs
Deferasirox 180mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback